Article
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype
4 Mar 2011
Abstract excerpt
To integrate available clinical and molecular information for cytogenetically normal acute myeloid leukemia (CN-AML) patients into one risk score, 275 CN-AML patients from multicenter treatment trials AML SHG Hannover 0199 and 0295 and 131 patients from HOVON/SAKK protocols as external controls were evaluated for mutations/polymorphisms in NPM1, FLT3, CEBPA, MLL, NRAS, IDH1/2, and WT1. Transcript levels were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
